Protara Therapeutics, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protara Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Protara Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -55 %, a 13.5% increase year-over-year.
  • Protara Therapeutics, Inc. annual Return On Equity for 2023 was -49.7 %, a 1.55% decline from 2022.
  • Protara Therapeutics, Inc. annual Return On Equity for 2022 was -49 %, a 81% decline from 2021.
  • Protara Therapeutics, Inc. annual Return On Equity for 2021 was -27.1 %, a 3.09% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -49.7 -0.76 -1.55% Jan 1, 2023 Dec 31, 2023
2022 -49 -21.9 -81% Jan 1, 2022 Dec 31, 2022
2021 -27.1 -0.81 -3.09% Jan 1, 2021 Dec 31, 2021
2020 -26.2 +873 +97.1% Jan 1, 2020 Dec 31, 2020
2019 -899 -801 -819% Jan 1, 2019 Dec 31, 2019
2018 -97.8 -10.2 -11.6% Jan 1, 2018 Dec 31, 2018
2017 -87.7 -28.1 -47.2% Jan 1, 2017 Dec 31, 2017
2016 -59.6 -29.5 -98.1% Jan 1, 2016 Dec 31, 2016
2015 -30.1 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.